MyFinsight
Home
Blog
About
Biopharmaceutical And Other
Biopharmaceutical Revenue
$802K
Testing
$145,661K
(19.14%↑ Y/Y)
Product
$3,858K
(7.23%↑ Y/Y)
Biopharmaceutical And Other
$802K
(-81.36%↓ Y/Y)
Total revenue
$150,321K
(15.49%↑ Y/Y)
Gross profit
$108,549K
(20.92%↑ Y/Y)
Total cost of revenue
$41,772K
(3.41%↑ Y/Y)
Income (loss) from
operations
$22,980K
(536.22%↑ Y/Y)
Other income, net
$3,543K
(-45.64%↓ Y/Y)
Total operating
expenses
$85,569K
(-9.96%↓ Y/Y)
Cost of
revenue-Testing
$36,309K
(12.04%↑ Y/Y)
Intangible asset
amortization - cost of revenue
$2,741K
(2.77%↑ Y/Y)
Cost of
revenue-Product
$2,515K
(43.80%↑ Y/Y)
Cost of
revenue-Biopharmaceutical And Other
$207K
(-94.20%↓ Y/Y)
Income before income
taxes
$26,523K
(2021.84%↑ Y/Y)
Research and development
$29,442K
(81.03%↑ Y/Y)
Selling and marketing
$28,263K
(11.64%↑ Y/Y)
General and
administrative
$27,443K
(-15.12%↓ Y/Y)
Intangible asset
amortization - operating...
$421K
(-32.21%↓ Y/Y)
Net income (loss)
$25,490K
(2701.02%↑ Y/Y)
Income tax provision
$1,033K
(-53.68%↓ Y/Y)
Back
Back
Income Statement
VERACYTE, INC. (VCYT)
VERACYTE, INC. (VCYT)
source: myfinsight.com